Head and neck cancer trials in Argentina

3 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  Where

  Buenos Aires, Pilar, Rosario, Santa Fe

  Age

  18 years and over

  People

  650 worldwide

  Run by

  Bicara Therapeutics

  See details and how to joinNCT06788990 · EU 2024-519654-37-00
• Phase 1/2Taking people
  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Where

  Buenos Aires, Caba, Ciudad Autonoma Buenos Aires, Mar del Plata

  Age

  18 years and over

  People

  680 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06330064 · EU 2023-509632-26-00
• Phase 3Taking people
  A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  Where

  Buenos Aires, Ciudad Autonoma de Buenos Aire, Córdoba, Florida, Rosario, San Juan, San Miguel de Tucumán, Viedma

  Age

  18 years and over

  People

  864 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT06256588 · EU 2023-508613-17-00